Company Filing History:
Years Active: 2016
Title: Gary Kinasewitz: Innovator in Sepsis Treatment
Introduction
Gary Kinasewitz is a notable inventor based in Edmond, OK (US). He has made significant contributions to the field of medicine, particularly in the treatment of sepsis. His innovative approach focuses on utilizing complement inhibitors to address this critical condition.
Latest Patents
Gary Kinasewitz holds 1 patent for his work titled "Treatment of sepsis using complement inhibitors." This patent discloses methods for treating sepsis with complement inhibitors, specifically C3 inhibitors like Compstatin and its analogs. These inhibitors are administered at various times following the onset of sepsis to mitigate tissue damage and organ failure, which are characteristic of the second, extravascular stage of the disease. The patent also discusses combination therapies for a comprehensive treatment of sepsis, along with pharmaceutical compositions and kits designed for these methods.
Career Highlights
Kinasewitz is affiliated with the University of Pennsylvania, where he continues to advance research in the medical field. His work has the potential to significantly improve patient outcomes in sepsis treatment, a condition that poses serious health risks.
Collaborations
Some of his notable coworkers include John D Lambris and Fletcher B Taylor, who have collaborated with him on various research initiatives.
Conclusion
Gary Kinasewitz's innovative work in the treatment of sepsis through complement inhibitors showcases his dedication to advancing medical science. His contributions are vital in the ongoing fight against this life-threatening condition.